Ichlibitiche commited on
Commit
5d987be
·
verified ·
1 Parent(s): 2f942cf

docs: shopfront moved to dataengineered.io

Browse files
Files changed (1) hide show
  1. README.md +73 -73
README.md CHANGED
@@ -1,73 +1,73 @@
1
- ---
2
- license: cc-by-nc-4.0
3
- pretty_name: "CSA — Clinical-Stage Asset Intelligence (Free Sample)"
4
- task_categories:
5
- - tabular-classification
6
- tags:
7
- - biotech
8
- - clinical-trials
9
- - finance
10
- - pharmaceuticals
11
- - catalyst-calendar
12
- - healthcare
13
- size_categories:
14
- - n<1K
15
- configs:
16
- - config_name: catalyst_calendar
17
- data_files: catalyst_calendar_sample.csv
18
- default: true
19
- - config_name: asset_master
20
- data_files: asset_master_sample.csv
21
- ---
22
-
23
- # CSA — Clinical-Stage Asset Intelligence · Free Sample
24
-
25
- **Clinical trials, FDA, and SEC — linked to the drug asset and the listed sponsor, with a
26
- forward catalyst calendar.** This is a free 150-row sample of the nearest-term
27
- catalysts; the full snapshot carries **2,103 forward catalysts** across
28
- **139 listed sponsors** and **1,841 resolved assets**.
29
-
30
- > **Data, not investment advice.** CSA is information, not a recommendation to buy, sell,
31
- > or hold any security. Estimated catalyst dates (e.g. protocol primary-completion dates)
32
- > routinely slip and are graded by confidence — verify anything material against the
33
- > `source_url` on each row.
34
-
35
- ## What's inside
36
-
37
- | File | Rows | What it is |
38
- | :-- | :-- | :-- |
39
- | `catalyst_calendar_sample.csv` | 150 | Nearest-term forward catalysts (2026-07-18 → 2027-09-01), 108 assets, 50 sponsors. |
40
- | `asset_master_sample.csv` | 464 | The asset ↔ trial ↔ sponsor ↔ ticker rows behind them. |
41
- | `*_sample.json` | — | The same tables as records-oriented JSON. |
42
-
43
- ### `catalyst_calendar_sample.csv`
44
- `event_date` · `ticker` · `asset` · `event_type` (PDUFA / READOUT / …) · `event_window`
45
- · `date_precision` · `confidence` · `source` (sec_8k / clinicaltrials) · `nct_id` · `source_url`.
46
-
47
- ### `asset_master_sample.csv`
48
- `asset` · `nct_id` · `phase` · `status` · `primary_completion` · `conditions` · `arm_role`
49
- · `sponsor_raw` · `company_name` · `ticker`.
50
-
51
- ## How it's built
52
-
53
- - **Active-moiety resolution** keys each asset to its FDA-registered UNII set (GSRS), not
54
- fuzzy names — audited to **zero cross-molecule merges**.
55
- - **Sponsor → listed ticker** through acquisitions, to the primary US listing.
56
- - **Dual-channel catalysts**: SEC 8-K disclosure text + active late-phase
57
- ClinicalTrials.gov protocol readouts. Every row carries its source.
58
-
59
- Sample scope: active, industry-sponsored, Phase 3 trials in cardiometabolic, oncology and
60
- immunology. Asset names are normalized for readability; the sample is curated to
61
- clinical-stage, single-sponsor assets.
62
-
63
- ## Sources & license
64
-
65
- All primary sources are U.S. Government / public domain: **ClinicalTrials.gov**,
66
- **openFDA**, **SEC EDGAR**, **GSRS/UNII**. This sample is released under **CC-BY-NC-4.0**
67
- (free to use and share with attribution, not to re-sell). See `SAMPLE_LICENSE.md`.
68
-
69
- ## Get the full dataset
70
-
71
- The complete, commercially-licensed snapshot (all 2,103 catalysts, CSV +
72
- JSON, monthly editions + delta feed) → **https://csa-public.pages.dev**
73
- · code: **https://github.com/CSA-pub/CSA-public** · contact: **https://csa-public.pages.dev/#contact**
 
1
+ ---
2
+ license: cc-by-nc-4.0
3
+ pretty_name: "CSA — Clinical-Stage Asset Intelligence (Free Sample)"
4
+ task_categories:
5
+ - tabular-classification
6
+ tags:
7
+ - biotech
8
+ - clinical-trials
9
+ - finance
10
+ - pharmaceuticals
11
+ - catalyst-calendar
12
+ - healthcare
13
+ size_categories:
14
+ - n<1K
15
+ configs:
16
+ - config_name: catalyst_calendar
17
+ data_files: catalyst_calendar_sample.csv
18
+ default: true
19
+ - config_name: asset_master
20
+ data_files: asset_master_sample.csv
21
+ ---
22
+
23
+ # CSA — Clinical-Stage Asset Intelligence · Free Sample
24
+
25
+ **Clinical trials, FDA, and SEC — linked to the drug asset and the listed sponsor, with a
26
+ forward catalyst calendar.** This is a free 150-row sample of the nearest-term
27
+ catalysts; the full snapshot carries **2,103 forward catalysts** across
28
+ **139 listed sponsors** and **1,841 resolved assets**.
29
+
30
+ > **Data, not investment advice.** CSA is information, not a recommendation to buy, sell,
31
+ > or hold any security. Estimated catalyst dates (e.g. protocol primary-completion dates)
32
+ > routinely slip and are graded by confidence — verify anything material against the
33
+ > `source_url` on each row.
34
+
35
+ ## What's inside
36
+
37
+ | File | Rows | What it is |
38
+ | :-- | :-- | :-- |
39
+ | `catalyst_calendar_sample.csv` | 150 | Nearest-term forward catalysts (2026-07-18 → 2027-09-01), 108 assets, 50 sponsors. |
40
+ | `asset_master_sample.csv` | 464 | The asset ↔ trial ↔ sponsor ↔ ticker rows behind them. |
41
+ | `*_sample.json` | — | The same tables as records-oriented JSON. |
42
+
43
+ ### `catalyst_calendar_sample.csv`
44
+ `event_date` · `ticker` · `asset` · `event_type` (PDUFA / READOUT / …) · `event_window`
45
+ · `date_precision` · `confidence` · `source` (sec_8k / clinicaltrials) · `nct_id` · `source_url`.
46
+
47
+ ### `asset_master_sample.csv`
48
+ `asset` · `nct_id` · `phase` · `status` · `primary_completion` · `conditions` · `arm_role`
49
+ · `sponsor_raw` · `company_name` · `ticker`.
50
+
51
+ ## How it's built
52
+
53
+ - **Active-moiety resolution** keys each asset to its FDA-registered UNII set (GSRS), not
54
+ fuzzy names — audited to **zero cross-molecule merges**.
55
+ - **Sponsor → listed ticker** through acquisitions, to the primary US listing.
56
+ - **Dual-channel catalysts**: SEC 8-K disclosure text + active late-phase
57
+ ClinicalTrials.gov protocol readouts. Every row carries its source.
58
+
59
+ Sample scope: active, industry-sponsored, Phase 3 trials in cardiometabolic, oncology and
60
+ immunology. Asset names are normalized for readability; the sample is curated to
61
+ clinical-stage, single-sponsor assets.
62
+
63
+ ## Sources & license
64
+
65
+ All primary sources are U.S. Government / public domain: **ClinicalTrials.gov**,
66
+ **openFDA**, **SEC EDGAR**, **GSRS/UNII**. This sample is released under **CC-BY-NC-4.0**
67
+ (free to use and share with attribution, not to re-sell). See `SAMPLE_LICENSE.md`.
68
+
69
+ ## Get the full dataset
70
+
71
+ The complete, commercially-licensed snapshot (all 2,103 catalysts, CSV +
72
+ JSON, monthly editions + delta feed) → **https://csa.dataengineered.io**
73
+ · code: **https://github.com/CSA-pub/CSA-public** · contact: **https://csa.dataengineered.io/#contact**